Protalix BioTherapeutics, Inc.PLXEarnings & Financial Report
NYSE · Health Care · Biological Products, (No Diagnostic Substances)
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Angels Investments in Hi Tech Ltd | 2.90% | 2.2M | — | 2024-01-02 |
| Whitebox Advisors LLC | 0.00% | 74.4K | — | 2024-10-25 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.